Clinical and pharmacologic evaluation of two dose levels of intetumumab (CNTO 95) in patients with melanoma or angiosarcoma. (Q54611969)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Clinical and pharmacologic evaluation of two dose levels of intetumumab (CNTO 95) in patients with melanoma or angiosarcoma. |
scientific article |
Statements
Clinical and pharmacologic evaluation of two dose levels of intetumumab (CNTO 95) in patients with melanoma or angiosarcoma. (English)
Steven J O'Day
Anna C Pavlick
Mark R Albertini
Omid Hamid
Heidi Schalch
Zhihui Lang
Jie Ling
Marielena Mata
Manjula Reddy
Brenda Foster
18 February 2011
30
3
1074-1081
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference